QTTB
QTTB
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
2
$30.00M
Insider Sales
14
$537K
Total Volume
$30.54M
21 transactions
Net Activity
+$29.46M
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Strong buying bias: purchases represent 98% of total transaction value.
- •Minor cluster buying: 2 unique insiders purchased shares.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
S - Sale Insiders
$1171.88B total
Xu Diyong
Dir, 10%
$15.00M total
Orbimed Advisors LLC
Dir, 10%
$15.00M total
Morrison Jodie Pope
CEO
$331K total
Kalowski Lee
CFO, Pres
$134K total
Quick Actions
QTTB has an insider buy conviction of 98%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at QTTB (QTTB) engaged in a total of 21 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 14 were sales. The total volume of insider trading reached $30.54M.
The net insider activity for QTTB shows a net buying bias of $29.46M. This activity represents a 98% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 625.0K shares valued at $1171.88B on May 28, 2026.
Down 23.1% in 4 Weeks, Here's Why Q32 Bio (QTTB) Looks Ripe for a Turnaround
QTTB - Q32 Bio Inc Stock Price and Quote
(QTTB) Price Dynamics and Execution-Aware Positioning
$QTTB stock is down 15% today. Here's what we see in our data.
Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Wall Street Analysts See an 182.18% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?
FAQs About QTTB Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for QTTB.